Carlsmed Launches Initial Public Offering
Carlsmed is a commercial-stage medical technology company offering artificial intelligence-enabled personalized spine surgery solutions....
Jul 15, 2025,
Carlsmed Launches Initial Public Offering
Shoulder Innovations Files for $100 Million IPO
The company offers implant systems for shoulder arthroplasty, as well as enabling technologies, instrument systems, support and surgeon-to-surgeon collaboration....
Jul 15, 2025,
Auction of Interest in the Collateral of Integrated Endoscopy
Substantially all assets of the company are for sale, including the NUVIS wireless arthroscopy platform....
Jul 15, 2025,
SurGenTec Launches INSITE Sterile Surgery-Ready Kit
The INSITE kit for SI fusion features a complete set of single-use, sterile instruments paired with a 3D-printed titanium implant....
Jul 15, 2025,
Wenzel Spine Gains 510(k) for panaSIa Expandable SI Fusion Implant
Its expandable architecture allows the implant to pierce the ilium and sacrum, stabilizing the SI joint and enabling post-expansion graft...
Jul 15, 2025,
IMPLANET JAZZ Range Approved in China
IMPLANET and distribution partner Sanyou Medical have registered the JAZZ range, dedicated to tape fixation in the treatment of spinal...
Jul 15, 2025,
Zimmer Biomet to Acquire Monogram Technologies
Monogram has developed a CT-based, semi-autonomous, artificial intelligence-navigated total knee arthroplasty robotic technology....
Jul 14, 2025,
What We’re Watching: 2025 Second Quarter Earnings Results
In this short video, we look the sluggish start to 2025, the changing competitive landscape and Globus Medical's steady execution....
Jul 14, 2025,
First Case with MOBIO Total Knee and TMINI Robotic System
THINK Surgical gained FDA 510(k) clearance for use of b-ONE Ortho's MOBIO with TMINI in 2024....
Jul 11, 2025,
Nanochon Gains Approval for Clinical Trial in Canada
Nanochon Chondrograft will be evaluated in a first in human study for use in knee cartilage restoration in eligible patients....
Jul 11, 2025,
Loading new posts...
No more posts
